Table 1.
Baseline characteristics of the first 100 home option testing for pre-exposure prophylaxis trial enrollees, March 2022-May 2023.
| Characteristics | Values | |
| Age (years), median (IQR) | 34 (28-39) | |
| Male sex assigned at birth, n (%) | 47 (47) | |
| Current gender identity, n (%) | ||
|
|
Cisgender man | 41 (87) |
|
|
Transgender, nonbinary, genderqueer, etc | 6 (11) |
| Race and ethnicity, n (%) | ||
|
|
NHa Black | 10 (11) |
|
|
Hispanic or Latinx | 15 (16) |
|
|
NHa White | 36 (38) |
|
|
Asian | 23 (24) |
|
|
American Indian or Alaska native, mixed race, or other | 8 (9) |
| Sexual orientation, n (%) | ||
|
|
Gay | 42 (89) |
|
|
Straight, pansexual, bisexual, or queer | 5 (11) |
| Annual income (US$), n (%) | ||
|
|
14,999 or less | 5 (11) |
|
|
15,000-29,999 | 6 (14) |
|
|
30,000-49,999 | 11 (25) |
|
|
50,000-99,999 | 11 (25) |
|
|
100,000 or more | 11 (25) |
| Highest level of education, n (%) | ||
|
|
Grade or high school | 4 (8) |
|
|
Some college, associate, or technical degree | 11 (23) |
|
|
Bachelor’s degree | 17 (35) |
|
|
Some graduate school | 5 (11) |
|
|
Graduate degree | 11 (23) |
| Medical insurance (excluding PrEPb care), n (%) | ||
|
|
None | 17 (37) |
|
|
Private insurance | 24 (52) |
|
|
Medicaid | 2 (4) |
|
|
Other insurance type | 3 (7) |
| Ever diagnosed with STIc, n (%) | ||
|
|
Yes | 33 (70) |
|
|
No | 14 (30) |
| PrEPb use status, n (%) | ||
|
|
Currently taking PrEPb | 42 (89) |
|
|
Planning to start soon | 5 (11) |
| Duration of current PrEPb use, n (%) | ||
|
|
<3 months | 3 (7) |
|
|
3-6 months | 8 (20) |
|
|
6-12 months | 6 (14) |
|
|
1-2 years | 8 (20) |
|
|
>2 years | 16 (39) |
| Substance use in the past 12 monthsd, n (%) | ||
|
|
Alcohol | 37 (37) |
|
|
Stimulants (cocaine or meth) | 9 (9) |
|
|
Hallucinogens (LSD or mushrooms) | 6 (6) |
|
|
Marijuana | 25 (25) |
|
|
None | 5 (5) |
aNH: non-Hispanic.
bPrEP: pre-exposure prophylaxis.
cSTI: sexually transmitted infections.
dTotal percentages may not sum to 100% as participants could select multiple answer choices.